A Randomized, Multicenter, Double Blind, Phase III Study of Nivolumab or Placebo in Subjects with Resected Lower Esophageal, or Gastroesophageal Junction Cancer - Regional Cancer Care Associates LLC

Clinical Trials

A Randomized, Multicenter, Double Blind, Phase III Study of Nivolumab or Placebo in Subjects with Resected Lower Esophageal, or Gastroesophageal Junction Cancer

Type of Cancer
Gastrointestinal
Locations
Hackensack
Sponsor
Bristol-Myers Squibb
Protocol Number
CA209-577
Cancer Diagnosis
To Learn More Call
201-510-0910